Gene transfer to human joints: Progress toward a gene therapy of arthritis

Christopher H. Evans, Paul D. Robbins, Steven C. Ghivizzani, Mary Chester Wasko, Matthew M. Tomaino, Richard Kang, Thomas A. Muzzonigro, Molly Vogt, Elaine M. Elder, Theresa L. Whiteside, Simon C. Watkins, James H. Herndon

Research output: Contribution to journalArticlepeer-review

159 Scopus citations


This article describes the clinical application of gene therapy to a nonlethal disease, rheumatoid arthritis (RA). Intraarticular transfer of IL-1 receptor antagonist (IL-1Ra) cDNA reduces disease in animal models of RA. Whether this procedure is safe and feasible in humans was addressed in a phase I clinical study involving nine postmenopausal women with advanced RA who required unilateral sialastic implant arthroplasty of the 2nd-5th metacarpophalangeal (MCP) joints. Cultures of autologous synovial fibroblasts were established and divided into two. One was transduced with a retrovirus carrying IL-1Ra cDNA; the other provided untransduced, control cells. In a dose escalation, double-blinded fashion, two MCP joints were injected with transduced cells, and two MCP joints received control cells. One week later, injected joints were resected and examined for evidence of successful gene transfer and expression by using RT-PCR, ex vivo production of IL-1Ra, in situ hybridization, and immunohistochemistry. All subjects tolerated the protocol well, without adverse events. Unlike control joints, those receiving transduced cells gave positive RT-PCR signals. Synovia that were recovered from the MCP joints of intermediate and high dose subjects produced elevated amounts of IL-1Ra (P = 0.01). Clusters of cells expressing high levels of IL-1Ra were present on synovia of transduced joints. No adverse events occurred. Thus, it is possible to transfer a potentially therapeutic gene safely to human rheumatoid joints and to obtain intraarticular, transgene expression. This conclusion justifies additional efficacy studies and encourages further development of genetic approaches to the treatment of arthritis and related disorders.

Original languageEnglish (US)
Pages (from-to)8698-8703
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number24
StatePublished - Jun 14 2005


  • Clinical trial
  • Interleukin-1 receptor antagonist
  • Retrovirus
  • Synovium

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Gene transfer to human joints: Progress toward a gene therapy of arthritis'. Together they form a unique fingerprint.

Cite this